
### [MONDO:0019517](http://purl.obolibrary.org/obo/MONDO_0019517)
**Label:** Waardenburg syndrome type 2

**Subclasses:** [MONDO:0008671](http://purl.obolibrary.org/obo/MONDO_0008671) (Waardenburg syndrome type 2A), [MONDO:0012144](http://purl.obolibrary.org/obo/MONDO_0012144) (Waardenburg syndrome type 2D), [MONDO:0010841](http://purl.obolibrary.org/obo/MONDO_0010841) (Waardenburg syndrome type 2B), [MONDO:0012698](http://purl.obolibrary.org/obo/MONDO_0012698) (Waardenburg syndrome type 2E), [MONDO:0011697](http://purl.obolibrary.org/obo/MONDO_0011697) (Waardenburg syndrome type 2C), 

**Mapped go classes:** [GO:0048839](http://purl.obolibrary.org/obo/GO_0048839) (inner ear development), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0061138](http://purl.obolibrary.org/obo/GO_0061138) (morphogenesis of a branching epithelium), [GO:0006368](http://purl.obolibrary.org/obo/GO_0006368) (transcription elongation from RNA polymerase II promoter), [GO:0000980](http://purl.obolibrary.org/obo/GO_0000980) (RNA polymerase II distal enhancer sequence-specific DNA binding), [GO:0022010](http://purl.obolibrary.org/obo/GO_0022010) (central nervous system myelination), [GO:0048484](http://purl.obolibrary.org/obo/GO_0048484) (enteric nervous system development), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0022011](http://purl.obolibrary.org/obo/GO_0022011) (myelination in peripheral nervous system), [GO:1990841](http://purl.obolibrary.org/obo/GO_1990841) (promoter-specific chromatin binding), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0048840](http://purl.obolibrary.org/obo/GO_0048840) (otolith development), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0032808](http://purl.obolibrary.org/obo/GO_0032808) (lacrimal gland development), [GO:0043473](http://purl.obolibrary.org/obo/GO_0043473) (pigmentation), [GO:0016055](http://purl.obolibrary.org/obo/GO_0016055) (Wnt signaling pathway), [GO:0001190](http://purl.obolibrary.org/obo/GO_0001190) (transcriptional activator activity, RNA polymerase II transcription factor binding), [GO:0031315](http://purl.obolibrary.org/obo/GO_0031315) (extrinsic component of mitochondrial outer membrane), [GO:0070888](http://purl.obolibrary.org/obo/GO_0070888) (E-box binding), [GO:0014037](http://purl.obolibrary.org/obo/GO_0014037) (Schwann cell differentiation), [GO:2001141](http://purl.obolibrary.org/obo/GO_2001141) (regulation of RNA biosynthetic process), [GO:0014032](http://purl.obolibrary.org/obo/GO_0014032) (neural crest cell development), [GO:0007422](http://purl.obolibrary.org/obo/GO_0007422) (peripheral nervous system development), [GO:0002052](http://purl.obolibrary.org/obo/GO_0002052) (positive regulation of neuroblast proliferation), [GO:0046983](http://purl.obolibrary.org/obo/GO_0046983) (protein dimerization activity), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0007623](http://purl.obolibrary.org/obo/GO_0007623) (circadian rhythm), [GO:0000981](http://purl.obolibrary.org/obo/GO_0000981) (RNA polymerase II transcription factor activity, sequence-specific DNA binding), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0010626](http://purl.obolibrary.org/obo/GO_0010626) (negative regulation of Schwann cell proliferation), [GO:0001755](http://purl.obolibrary.org/obo/GO_0001755) (neural crest cell migration), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0010468](http://purl.obolibrary.org/obo/GO_0010468) (regulation of gene expression), [GO:0071600](http://purl.obolibrary.org/obo/GO_0071600) (otic vesicle morphogenesis), [GO:0050768](http://purl.obolibrary.org/obo/GO_0050768) (negative regulation of neurogenesis), [GO:0014003](http://purl.obolibrary.org/obo/GO_0014003) (oligodendrocyte development), [GO:0014044](http://purl.obolibrary.org/obo/GO_0014044) (Schwann cell development), [GO:0006461](http://purl.obolibrary.org/obo/GO_0006461) (protein complex assembly), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0044336](http://purl.obolibrary.org/obo/GO_0044336) (canonical Wnt signaling pathway involved in negative regulation of apoptotic process), [GO:0021772](http://purl.obolibrary.org/obo/GO_0021772) (olfactory bulb development), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0048066](http://purl.obolibrary.org/obo/GO_0048066) (developmental pigmentation), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0045670](http://purl.obolibrary.org/obo/GO_0045670) (regulation of osteoclast differentiation), [GO:0043010](http://purl.obolibrary.org/obo/GO_0043010) (camera-type eye development), [GO:0003705](http://purl.obolibrary.org/obo/GO_0003705) (transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding), [GO:0050931](http://purl.obolibrary.org/obo/GO_0050931) (pigment cell differentiation), [GO:0014015](http://purl.obolibrary.org/obo/GO_0014015) (positive regulation of gliogenesis), [GO:0048709](http://purl.obolibrary.org/obo/GO_0048709) (oligodendrocyte differentiation), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0046849](http://purl.obolibrary.org/obo/GO_0046849) (bone remodeling), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:1904888](http://purl.obolibrary.org/obo/GO_1904888) (cranial skeletal system development), [GO:0048469](http://purl.obolibrary.org/obo/GO_0048469) (cell maturation), [GO:0048546](http://purl.obolibrary.org/obo/GO_0048546) (digestive tract morphogenesis), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0048589](http://purl.obolibrary.org/obo/GO_0048589) (developmental growth), [GO:0005741](http://purl.obolibrary.org/obo/GO_0005741) (mitochondrial outer membrane), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0030316](http://purl.obolibrary.org/obo/GO_0030316) (osteoclast differentiation), [GO:0003676](http://purl.obolibrary.org/obo/GO_0003676) (nucleic acid binding), [GO:0090090](http://purl.obolibrary.org/obo/GO_0090090) (negative regulation of canonical Wnt signaling pathway), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0030318](http://purl.obolibrary.org/obo/GO_0030318) (melanocyte differentiation), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0048752](http://purl.obolibrary.org/obo/GO_0048752) (semicircular canal morphogenesis), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0045165](http://purl.obolibrary.org/obo/GO_0045165) (cell fate commitment), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:2000144](http://purl.obolibrary.org/obo/GO_2000144) (positive regulation of DNA-templated transcription, initiation), [GO:0010001](http://purl.obolibrary.org/obo/GO_0010001) (glial cell differentiation), [GO:0031643](http://purl.obolibrary.org/obo/GO_0031643) (positive regulation of myelination), 

**Class expressions from DL-Learner:**

- Thing 53.20%
- [GO:1904888](http://purl.obolibrary.org/obo/GO_1904888) (cranial skeletal system development) 52.00%
- [GO:0071600](http://purl.obolibrary.org/obo/GO_0071600) (otic vesicle morphogenesis) 52.00%
- [GO:0048840](http://purl.obolibrary.org/obo/GO_0048840) (otolith development) 52.00%
- [GO:0048752](http://purl.obolibrary.org/obo/GO_0048752) (semicircular canal morphogenesis) 52.00%
- [GO:0048484](http://purl.obolibrary.org/obo/GO_0048484) (enteric nervous system development) 52.00%
- [GO:0046849](http://purl.obolibrary.org/obo/GO_0046849) (bone remodeling) 52.00%
- [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development) 52.00%
- [GO:0042472](http://purl.obolibrary.org/obo/GO_0042472) (inner ear morphogenesis) 52.00%
- [GO:0032808](http://purl.obolibrary.org/obo/GO_0032808) (lacrimal gland development) 52.00%
- [GO:0032292](http://purl.obolibrary.org/obo/GO_0032292) (peripheral nervous system axon ensheathment) 52.00%
- [GO:0032291](http://purl.obolibrary.org/obo/GO_0032291) (axon ensheathment in central nervous system) 52.00%
- [GO:0022011](http://purl.obolibrary.org/obo/GO_0022011) (myelination in peripheral nervous system) 52.00%
- [GO:0022010](http://purl.obolibrary.org/obo/GO_0022010) (central nervous system myelination) 52.00%
- [GO:0021772](http://purl.obolibrary.org/obo/GO_0021772) (olfactory bulb development) 52.00%


